Overview

Retrospective Study to Capture Dosing and Treatment Outcome Data in Participants With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
This is a data collection study with the purpose of capturing dosing and treatment outcome data in participants with severe congenital protein C deficiency who were treated with protein C concentrate under an Emergency Use Investigational New Drug Application (IND).
Details
Lead Sponsor:
Baxalta now part of Shire
Baxalta US Inc.
Treatments:
Protein C